Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00912_DB00976_nanopub.RAKVTI--3wYybkgD-oQy5PDKBe5JQ3ir5-pFnS9v86yhg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00912_DB00976 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00912_DB00976 label "DDI between Repaglinide and Telithromycin - Telithromycin may reduce clearance of Repaglinide. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Repaglinide if Telithromycin is initiated, discontinued or dose changed. [drugbank_resource:DB00912_DB00976]" assertion.
- drugbank_resource:DB00912_DB00976 identifier "drugbank_resource:DB00912_DB00976" assertion.
- drugbank_resource:DB00912_DB00976 title "DDI between Repaglinide and Telithromycin - Telithromycin may reduce clearance of Repaglinide. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Repaglinide if Telithromycin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00912 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00912_DB00976 assertion.
- drugbank:DB00976 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00912_DB00976 assertion.